Sanofi’s mRNA Vaccine Won’t Be Ready This Year, CEO Tells JDD


Sanofi’s messenger RNA-based vaccine won’t be ready this year, the French weekly Journal du Dimanche said in a Q&A interview with the French drugmaker’s chief executive, Paul Hudson.

A company official had said on Feb. 8 that it would likely be ready at the end of the year or the start of 2022.

Hudson noted in the interview that Sanofi will also start trials on mRNA-based vaccines for the flu.

©2021 Bloomberg L.P.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.